Inabata & Co., Ltd. (8098) - Financial and Strategic SWOT Analysis Review

Inabata & Co., Ltd. (8098) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Inabata & Co., Ltd. (Inabata) is a Japan-based trading company that trades plastics, chemicals, IT-related products, pharmaceutical, fruit juice and frozen vegetables. The company owns and operates manufacturing and processing base for compounding, molding and processing of resins and rubber. The company also has manufacturing units for processing of coating materials, plastic films, fine chemicals and processing of grip tape for racket sports. The company procures and sells plastics for automotive, home appliances, office automation, packaging material and beverages industries. It markets resin materials to resin manufacturer and rubber materials to automotive industry. Geographically, the company operates in Asia Pacific, North America, South America, Middle East and Europe. Inabata is headquartered in Chuo-ku, Osaka, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company 5
Gurit Holding AG - Key Facts 5
Gurit Holding AG - Key Employees 6
Gurit Holding AG - Key Employee Biographies 7
Gurit Holding AG - Major Products and Services 8
Gurit Holding AG - History 9
Gurit Holding AG - Company Statement 11
Gurit Holding AG - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 Company Analysis 17
Gurit Holding AG - Business Description 17
Gurit Holding AG - Corporate Strategy 18
Gurit Holding AG - SWOT Analysis 19
SWOT Analysis - Overview 19
Gurit Holding AG - Strengths 19
Gurit Holding AG - Weaknesses 20
Gurit Holding AG - Opportunities 21
Gurit Holding AG - Threats 22
Gurit Holding AG - Key Competitors 23
Section 3 Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Section 4 Companys Power Financial Deals and Alliances 31
Gurit Holding AG, Petrochemicals, Deals By Year, 2011 to YTD 2017 31
Gurit Holding AG, Petrochemicals, Deals By Type, 2011 to YTD 2017 32
Gurit Holding AG, Recent Deals Summary 33
Section 5 Companys Recent Developments 34
Oct 23, 2017: Gurit Achieves Slight Net Sales Growth For First Nine Months Of 2017 34
Oct 23, 2017: Gurit Achieves Slight Net Sales Growth For First Nine Months Of 2017 35
Aug 17, 2017: Gurit reports strategic progress and further profitability improvements for the first half-year 2017 36
Aug 25, 2016: Gurit Achieves Net Sales Growth Of 3% And A Strong Operating Profit Margin Of 10.5% In The First Half Of 2016 38
Jun 13, 2016: Gurit Opens Wind Blade Mould Production Facility in Europe 40
Apr 14, 2016: Gurit Reports Solid Start Into The 2016 Fiscal Year 41
Section 6 Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List Of Tables


Gurit Holding AG, Key Facts 5
Gurit Holding AG, Key Employees 6
Gurit Holding AG, Key Employee Biographies 7
Gurit Holding AG, Major Products and Services 8
Gurit Holding AG, History 9
Gurit Holding AG, Subsidiaries 15
Gurit Holding AG, Key Competitors 23
Gurit Holding AG, Ratios based on current share price 24
Gurit Holding AG, Annual Ratios 25
Gurit Holding AG, Annual Ratios (Cont...1) 26
Gurit Holding AG, Annual Ratios (Cont...2) 27
Gurit Holding AG, Interim Ratios 29
Gurit Holding AG, Petrochemicals, Deals By Year, 2011 to YTD 2017 31
Gurit Holding AG, Petrochemicals, Deals By Type, 2011 to YTD 2017 32
Gurit Holding AG, Recent Deals Summary 33
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

List Of Figures


Gurit Holding AG, Performance Chart (2012 - 2016) 28
Gurit Holding AG, Ratio Charts 30
Gurit Holding AG, Petrochemicals, Deals By Year, 2011 to YTD 2017 31
Gurit Holding AG, Petrochemicals, Deals by Type, 2011 to YTD 2017 32

Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review

Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Merck & Co., Inc. - Enterprise Tech Ecosystem Series

Merck & Co., Inc. - Enterprise Tech Ecosystem SeriesMerck & Co Inc. (Merck) is a multinational healthcare company that is engaged in the discovery, development, manufacture, and commercialization of prescription

USD 1495 View Report

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other CompaniesThis report presents an in-depth assessment

USD 1390 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available